On December 16, 2024, the U.S. Food and Drug Administration (FDA) announced a nationwide recall affecting 136,181 bottles of prescription eye solution, marketed as Ciprofloxacin Ophthalmic ...

Ciprofloxacin (as HCl) 0.3%, dexamethasone 0.1%; otic susp. Not for ophthalmic use, or for inj. Discontinue if superinfection or hypersensitivity occurs. Reevaluate if no improvement after 1 week.

Floxin Otic® (ofloxacin), Ciprodex® otic suspension (ciprofloxacin ... The following are safe ophthalmic preparations: Ciloxan® ophthalmic ointment and solution (cipro-floxacin), Vigamox ...